Analysts at Raymond James Financial Inc. upgraded shares of DaVita HealthCare Partners Inc. (NYSE: DVA) from Market Perform to Outperform today. The company currently has a rating of Outperform on the shares. A number of other analysts have commented on …

Analysts at Citigroup Inc. initiated coverage on DaVita HealthCare Partners Inc. (NYSE: DVA) stock, rating the company at Neutral and a price target of $71.00. As a means of comparison, a number of other analysts have commented on the company …

Analysts at Citigroup Inc. initiated coverage on DaVita HealthCare Partners Inc. (NYSE: DVA) stock, starting the company at Neutral and a price target of $71.00. As a means of comparison, a number of other analysts have commented on the shares …